NY-ESO-1 (87-111) – 1 mg

Overview

The NY-ESO-1 (87-111) peptide offers a powerful tool for cancer research and therapeutic applications. This specific fragment comprises amino acids 81 to 111 of the NY-ESO-1 antigen, which is prominently expressed in various tumor types, including breast, prostate, lung, and melanoma. By targeting this peptide, researchers can gain insights into tumor biology and T cell recognition.

Key Features

• Targeted fragment of the NY-ESO-1 antigen
• Expressed by multiple tumor types
• Recognized by T cells, aiding cancer immunotherapy
• Compatible with MHC class II-restricted binding
• Available in a convenient 1 mg format

Specifications

FAQ

What is the significance of NY-ESO-1?

The NY-ESO-1 antigen is associated with a range of tumors and is important for immune recognition, making it a focal point in cancer studies and therapies.

How is this peptide used in research?

Researchers utilize the NY-ESO-1 (87-111) peptide to investigate immune responses and develop immunotherapeutic strategies for cancer treatment.

Is NY-ESO-1 suitable for diagnostic applications?

Yes, due to its expression in various tumors, this peptide can be employed in diagnostic assays to help identify cancer types.

Shop for the NY-ESO-1 (87-111) peptide today and explore its potential applications for your research. Consider pairing it with our PKG Substrate for enhanced results. With a dedicated focus on cancer research, AnaSpec provides a range of peptides including our other offerings such as Autocamtide-2 and CREBtide. Ensure your research is built on high-quality components with NY-ESO-1 (87-111) from AnaSpec.

Browse more in Peptides.